The Selective estrogens , Menopause , And Response to Therapy ( SMART ) -5 trial was a multicenter , randomized , double-blind , PBO - and active-controlled study in postmenopausal women with an intact uterus ( N = 1843 ; aged 40-65 years ) seeking treatment for menopausal symptoms .